Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > FOXO4-DRI for Sale > Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - large image1
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - image1
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - image2
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - image3
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - image4
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - image5
Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard buy - image6

Hot sale FOXO4-DRI raw powder match with US,EU, cGMP standard

TDS 26 Inquiries

Unit Price: Get Latest Price
CAS No.:

2460055-10-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

hangzhou

Brand:

thinheal

Packaging:

1g/bag

Price valid (until):

2025-01-13

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Linaclotide,Semaglutide,Plecanatide,Retatrutide,Eptifibatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    FOXO4-DRI  CAS 2460055-10-9


    Product Name    FOXO4-DRI
    CAS.No 2460055-10-9
    Synonyms FOXO4-DRI;FOXO4 /FOXO4-DRI
    Purity 99%
    Application FOXO4-DRI is a cell-permeable peptide comprising part of the p53-interaction domain of FOXO4.  It can compete with endogenous FOXO4 for p53, thereby disrupting the FOXO4-p53 interaction. Disrupting the p53-FOXO4 interaction causes p53 to be excluded from the nucleus and directed to mitochondria for induction of apoptosis in senescent cells, ultimately eliminating senescent fibroblasts through triggering apoptosis[1-2]. FOXO4-DRI to be selective for ionizing radiation-induced senescent IMR90 cells and safe to normal cells. 



    FOXO4-DRI  CAS 2460055-10-9 Picture 


    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 1


      About us   


    Hangzhou ThinHeal Pharma-Tech Co., Ltd. is headquartered in Hangzhou, P.R. China. ThinHeal focuses on peptide products and our team has extensive experience in drug research and development with launched products in domestic markets and United States, Europe and Japan.

    ThinHeal is devoted to building an international peptide delivery system to provide customers one-stop solutions for peptide products. We have established an effective and scientific quality assurance system to meet the international application requirements; a 2,000 square meter R&D center in Hangzhou equipped with high performance liquid chromatography, mass spectrometry system, gas chromatography, freeze dryer, etc.; and seasoned employees that ensure the progress of R & D projects and products.

    Based on the above, we can provide customers all products about peptide: new peptide products, generics, full sets of peptide impurities, consistency evaluation technology development.

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 2 Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 3


      Equipment Display


    Synthesis Reactor

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 4

    Cleavage Reactor

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 5

    Preparative HPLC

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 6

    Lyophilizer

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 7


      Lab  


    HPLCs

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 8 Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 9

    LC-MS-MS & GCs

    Shop Hot sale Semaglutide raw powder match with US,EU, cGMP standard-Detailed Image 10


      Service 


    To meet the needs of customers for new drug development, impurity research, and quality improvement, the company provides customized services for high-end peptide products, including process development and product customization of drug peptide impurities, intermediates, peptide fragments, and peptide new drugs. Customized services can be upgraded according to customer product development needs, including a complete set of impurity preparation that meets registration requirements, GMP level peptide drug declaration, and production services.

    Certificates

    Basic Info
    Product Name:

    FOXO4-DRI

    Other Name:

    FOXO4-DRI;FOXO4 /FOXO4-DRI;FOX04-DRI (D-Retro-Inverso);Fox4-dri

    CAS No.:

    2460055-10-9

    Molecular Weight:

    0

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Linaclotide,Semaglutide,Plecanatide,Retatrutide,Eptifibatide

    Location:

    8th Floor, Building 2, Heji R&D Center, Xiasha Street, Qiantang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,L/C,100% TT in advance

    Average lead Time:

    20

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    201-300

    Year of Establishment:

    2019

    Hangzhou ThinHeal Co., Ltd.


     Misson 


    To make our company be the 

    1.The One-stop CRDMO Partner of Peptide Drugs

    2.The Cutting-edge Peptide Technology Innovator

    3.The Most Cost-effective Peptide Manufacturer

    4. The High Quality and Large Scale cGMP Peptide Supplier


    Introduction


    Hangzhou ThinHeal Co., Ltd.  is headquartered in Hangzhou, P.R. China. ThinHeal focuses on peptide products and our team has extensive experience in drug research and development with launched products in domestic markets and United States, Europe and Japan.

    ThinHeal is devoted to building an international peptide delivery system to provide customers one-stop solutions for peptide products. We have established an effective and scientific quality assurance system to meet the international application requirements; a 2,000 square meter R&D center in Hangzhou equipped with high performance liquid chromatography, mass spectrometry system, gas chromatography, freeze dryer, etc.; and seasoned employees that ensure the progress of R & D projects and products.

    Based on the above, we can provide customers all products about peptide: new peptide products, generics, full sets of peptide impurities, consistency evaluation technology development.


    Key andvantage  


    1.Recognized quality management system Based on Chinese GMP, 21CFR part 210, 211, EU cGMP Volume 4 and ICH Guidelines, ThinHeal has established a quality management system encompassing the product lifecycle, providing comprehensive quality assurance for the products.

    2. Effective project managements With abundant experience of multiple projects managements, ThinHeal can ensure the smooth and effective implementation of the projects per customer’s requirements.

    3. cGMP experiences With extensive cGMP management experiences, ThinHeal can undertake the product transfer, process validation, and commercial manufacturing according to the cGMP requirements of different countries (including China, the United States, the European Union, and Japan).

    4. Cost effective managements,Cost is always considered by ThinHeal during the peptide synthesis route selection, purification process optimization and the quality control. ThinHeal helps our customers improve the product quality with cost effective and efficient solutions.

    5. Platform for process development 

    API: up to 40 amino acids synthesis experience, including but not limited to the synthesis of linear peptide/cyclic peptide/multiple disulfide bonds; solid phase/liquid phase peptide synthesis & assembly coupling; peptide modification & Multi cyclic peptide synthesis. 

    Finished Products: including injection, oral controlled release preparation, long-term peptide injection process development and quality control, scale-up and stability study experience.

    6. More than 20 years experience for regulatory application and registration in both dosmetic and overseas.

  • Inquiry History
    26 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    FOXO4-DRI

    1 G Dec 3, 2023
    United States

    Fox04-dri

    1 G May 20, 2026
    United States

    hot-sale-high-purity-raw-powder-fox04-dri-nad-ghk-cu-mot

    2 PCS Dec 19, 2025
    United States

    foxo4 dri

    10 MT Dec 13, 2025
    United States

    Fox04

    10 MG Oct 30, 2024
    United Kingdom

    High purity foxo4

    1 G May 31, 2026
    United Kingdom

    Foxo4-Dri

    10 MG May 5, 2026
    United States

    Fox04-dri

    100 MG Apr 28, 2026
    Cyprus

    Foxo4 dri

    10 MT Apr 4, 2026
    Cyprus

    FOXO4-DRI

    1 KG Feb 2, 2026
    United States

    FOX04-DRI

    10 PCS Jan 12, 2026
    United States

    FOX04

    10 PCS Jan 12, 2026
    United States

    Foxo4 Dri

    40 MG Sep 15, 2025
    United States

    Fox04 dri

    10 MT Jun 21, 2026
    United States

    FOX04-DRI powder

    10 MT May 29, 2026
    United States

    fox04

    1 G Apr 29, 2026
    United States

    FOXO4-DRI

    1 KG Mar 23, 2026
    United States

    Foxo4-Dri

    Nov 24, 2025
    United States

    FOXO4

    10 PCS Nov 15, 2025
    United States

    Fox04

    1 G Nov 10, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.